Physician

Kevin George Barber, D.O.

According to 2025 Medicare claims, Kevin Barber, D.O. (NPI: 1861461196) practices nephrology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CUMBERLAND NEPHROLOGY ASSOCIATES (NPI: 1710956370; TIN: 223586136) and primary practice location at 08360-6516. Barber is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Barber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 464 traditional Medicare patients, billed 3,155 HCPCS/CPT codes, and received $240,968 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 3,428 prescription claims across 433 beneficiaries totaling $976,428 in drug costs, led by Rayaldee (Calcifediol). 2023 DME data shows 58 claims. Open Payments data shows 83 records totaling $1,420. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,904 to $170.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	789	4,885	$407,903
2016	705	5,525	$373,938
2017	701	5,052	$351,993
2018	688	5,521	$352,490
2019	645	5,056	$362,326
2020	548	4,295	$300,864
2021	524	3,595	$326,023
2022	490	2,936	$287,394
2023	510	2,710	$274,916
2024	464	3,155	$240,968

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	407	4,297	$989,531
2016	366	3,629	$859,129
2017	354	3,258	$688,796
2018	362	3,398	$482,801
2019	374	3,212	$475,955
2020	419	3,502	$562,082
2021	410	3,303	$566,568
2022	384	3,354	$622,492
2023	395	3,205	$539,617
2024	433	3,428	$976,428

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	161	$10,561
2016	N/R	194	$11,917
2017	N/R	195	$9,032
2018	N/R	193	$16,312
2019	N/R	118	$6,176
2020	N/R	96	$5,243
2021	N/R	61	$3,190
2022	N/R	12	$1,441
2023	N/R	58	$1,865
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	65	444	$284
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	145	251	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	209	447	$66
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	135	305	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	204	488	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rayaldee	Calcifediol	127	3,824	$148,766
Farxiga	Dapagliflozin Propanediol	103	7,680	$138,876
Repatha Sureclick	Evolocumab	67	5,040	$94,008
Kerendia	Finerenone	47	3,012	$61,831
Icosapent Ethyl	Icosapent Ethyl	55	3,510	$25,683

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$1,420	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin George Barber, D.O.?

Tedicare shows public-source Medicare data for Kevin George Barber, D.O. (NPI 1861461196), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin George Barber, D.O. have ACO affiliation data?

Kevin George Barber, D.O. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Kevin George Barber, D.O.?

Kevin George Barber, D.O. is linked to CUMBERLAND NEPHROLOGY ASSOCIATES (billing NPI 1710956370) in the available physician profile data.

Does Kevin George Barber, D.O. have Open Payments data?

Kevin George Barber, D.O. has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.